Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia

M. Ishikawa, T. Fujii, M. Saito, I. Nindl, A. Ono, K. Kubushiro, K. Tsukazaki, M. Mukai, S. Nozawa

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Overexpression of p16INK4a has been observed when retinoblastoma protein is inactivated by high-risk human papillomavirus (HPV) oncoprotein E7. We investigated overexpression of p16INK4a and HPV infection in cervical squamous neoplasia to evaluate the oncogenic potential among various HPV subtypes. The high-risk HPV was detected by PCR in 69.8% (37/53), 97.5% (39/40), 91.7% (44/48), and 100% (16/16) of cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous cell carcinoma (SCC), respectively. The p16INK4a overexpression was investigated immunohistochemically using a p16INK4a-specific monoclonal antibody (clone E6H4). In high-risk HPV positive cases, 32.4% (12/37) of CIN1, 82.1% (32/39) of CIN2, 93.2% (41/44) of CIN3, and all (16/16) SCC showed p16INK4a overexpression. The incidence of p16INK4a overexpression was significantly different between CIN1 and CIN2, suggesting that the disorder of cell cycle regulation by HPV frequently occurred from CIN2. As for CIN1 cases, p16INK4a overexpression was observed more frequently in HPV16 and HPV52 than in HPV51 and HPV35. Using p16INK4a as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.

Original languageEnglish
Pages (from-to)347-353
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume16
Issue number1
DOIs
Publication statusPublished - 01-01-2006
Externally publishedYes

Fingerprint

Neoplasms
Squamous Cell Carcinoma
Retinoblastoma Protein
Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Oncogene Proteins
Cell Cycle
Clone Cells
Monoclonal Antibodies
Polymerase Chain Reaction
Incidence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Ishikawa, M. ; Fujii, T. ; Saito, M. ; Nindl, I. ; Ono, A. ; Kubushiro, K. ; Tsukazaki, K. ; Mukai, M. ; Nozawa, S. / Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. In: International Journal of Gynecological Cancer. 2006 ; Vol. 16, No. 1. pp. 347-353.
@article{3102a9ff9e0943a693c179c42cfab0ff,
title = "Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia",
abstract = "Overexpression of p16INK4a has been observed when retinoblastoma protein is inactivated by high-risk human papillomavirus (HPV) oncoprotein E7. We investigated overexpression of p16INK4a and HPV infection in cervical squamous neoplasia to evaluate the oncogenic potential among various HPV subtypes. The high-risk HPV was detected by PCR in 69.8{\%} (37/53), 97.5{\%} (39/40), 91.7{\%} (44/48), and 100{\%} (16/16) of cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous cell carcinoma (SCC), respectively. The p16INK4a overexpression was investigated immunohistochemically using a p16INK4a-specific monoclonal antibody (clone E6H4). In high-risk HPV positive cases, 32.4{\%} (12/37) of CIN1, 82.1{\%} (32/39) of CIN2, 93.2{\%} (41/44) of CIN3, and all (16/16) SCC showed p16INK4a overexpression. The incidence of p16INK4a overexpression was significantly different between CIN1 and CIN2, suggesting that the disorder of cell cycle regulation by HPV frequently occurred from CIN2. As for CIN1 cases, p16INK4a overexpression was observed more frequently in HPV16 and HPV52 than in HPV51 and HPV35. Using p16INK4a as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.",
author = "M. Ishikawa and T. Fujii and M. Saito and I. Nindl and A. Ono and K. Kubushiro and K. Tsukazaki and M. Mukai and S. Nozawa",
year = "2006",
month = "1",
day = "1",
doi = "10.1111/j.1525-1438.2006.00355.x",
language = "English",
volume = "16",
pages = "347--353",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. / Ishikawa, M.; Fujii, T.; Saito, M.; Nindl, I.; Ono, A.; Kubushiro, K.; Tsukazaki, K.; Mukai, M.; Nozawa, S.

In: International Journal of Gynecological Cancer, Vol. 16, No. 1, 01.01.2006, p. 347-353.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia

AU - Ishikawa, M.

AU - Fujii, T.

AU - Saito, M.

AU - Nindl, I.

AU - Ono, A.

AU - Kubushiro, K.

AU - Tsukazaki, K.

AU - Mukai, M.

AU - Nozawa, S.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Overexpression of p16INK4a has been observed when retinoblastoma protein is inactivated by high-risk human papillomavirus (HPV) oncoprotein E7. We investigated overexpression of p16INK4a and HPV infection in cervical squamous neoplasia to evaluate the oncogenic potential among various HPV subtypes. The high-risk HPV was detected by PCR in 69.8% (37/53), 97.5% (39/40), 91.7% (44/48), and 100% (16/16) of cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous cell carcinoma (SCC), respectively. The p16INK4a overexpression was investigated immunohistochemically using a p16INK4a-specific monoclonal antibody (clone E6H4). In high-risk HPV positive cases, 32.4% (12/37) of CIN1, 82.1% (32/39) of CIN2, 93.2% (41/44) of CIN3, and all (16/16) SCC showed p16INK4a overexpression. The incidence of p16INK4a overexpression was significantly different between CIN1 and CIN2, suggesting that the disorder of cell cycle regulation by HPV frequently occurred from CIN2. As for CIN1 cases, p16INK4a overexpression was observed more frequently in HPV16 and HPV52 than in HPV51 and HPV35. Using p16INK4a as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.

AB - Overexpression of p16INK4a has been observed when retinoblastoma protein is inactivated by high-risk human papillomavirus (HPV) oncoprotein E7. We investigated overexpression of p16INK4a and HPV infection in cervical squamous neoplasia to evaluate the oncogenic potential among various HPV subtypes. The high-risk HPV was detected by PCR in 69.8% (37/53), 97.5% (39/40), 91.7% (44/48), and 100% (16/16) of cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, and squamous cell carcinoma (SCC), respectively. The p16INK4a overexpression was investigated immunohistochemically using a p16INK4a-specific monoclonal antibody (clone E6H4). In high-risk HPV positive cases, 32.4% (12/37) of CIN1, 82.1% (32/39) of CIN2, 93.2% (41/44) of CIN3, and all (16/16) SCC showed p16INK4a overexpression. The incidence of p16INK4a overexpression was significantly different between CIN1 and CIN2, suggesting that the disorder of cell cycle regulation by HPV frequently occurred from CIN2. As for CIN1 cases, p16INK4a overexpression was observed more frequently in HPV16 and HPV52 than in HPV51 and HPV35. Using p16INK4a as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.

UR - http://www.scopus.com/inward/record.url?scp=33645355917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645355917&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1438.2006.00355.x

DO - 10.1111/j.1525-1438.2006.00355.x

M3 - Article

C2 - 16445657

AN - SCOPUS:33645355917

VL - 16

SP - 347

EP - 353

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 1

ER -